Cogent Biosciences (COGT) advances bezuclastinib-sunitinib combination with breakthrough therapy designation (BTD)

Cogent Biosciences, Inc. (NASDAQ:COGT) is one of the 11 Best Performing Stocks in the Last 12 Months. On January 26, 2026, ...

Bloodhound Tracking Device Launches Tracker 1™: The New Standard in Global Container Intelligence

HOUSTON, TX, UNITED STATES, January 13, 2026 /EINPresswire.com/ -- Bloodhound Tracking Device (BTD) today announced the ...

Cogent Biosciences announcse U.S. BTD for bezuclastinib

Cogent Biosciences (COGT) announced that the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation, ...
Nasdaq

GSK’s GSK’227 receives FDA BTD for treating adults with relapsed osteosarcoma

GSK (GSK) announced that the US Food and Drug Administration, FDA, has granted Breakthrough Therapy Designation, BTD, for GSK5764227, GSK’227, its B7-H3-targeted antibody-drug conjugate being ...
Nature

Breakthrough therapy designations in China and the United States

Breakthrough therapy designation (BTD) is an expedited regulatory pathway designed to accelerate the development of novel therapies that potentially provide substantial clinical benefits, particularly ...